These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26934528)

  • 1. Predictors of fecal transplant failure.
    Meighani A; Hart BR; Mittal C; Miller N; John A; Ramesh M
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):826-30. PubMed ID: 26934528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
    Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
    Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC; Griesbach CL; DiBaise JK; Orenstein R
    Mayo Clin Proc; 2013 Aug; 88(8):799-805. PubMed ID: 23910407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
    Furuya-Kanamori L; Doi SA; Paterson DL; Helms SK; Yakob L; McKenzie SJ; Garborg K; Emanuelsson F; Stollman N; Kronman MP; Clark J; Huber CA; Riley TV; Clements AC
    J Clin Gastroenterol; 2017 Feb; 51(2):145-150. PubMed ID: 26974758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.
    Hefazi M; Patnaik MM; Hogan WJ; Litzow MR; Pardi DS; Khanna S
    Mayo Clin Proc; 2017 Nov; 92(11):1617-1624. PubMed ID: 29101931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
    Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
    Reigadas E; Olmedo M; Valerio M; Vázquez-Cuesta S; Alcalá L; Marín M; Muñoz P; Bouza E
    Rev Esp Quimioter; 2018 Oct; 31(5):411-418. PubMed ID: 30221898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with fecal microbiota transplantation in Clostridium difficile infection - transplant protocol and preliminary results.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Pinto-Pais T; Fernandes C; Ribeiro I; Rodrigues J; Lopes P; Teixeira T; Carvalho J
    Rev Esp Enferm Dig; 2015 Jul; 107(7):402-7. PubMed ID: 26140631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
    Lee CH; Steiner T; Petrof EO; Smieja M; Roscoe D; Nematallah A; Weese JS; Collins S; Moayyedi P; Crowther M; Ropeleski MJ; Jayaratne P; Higgins D; Li Y; Rau NV; Kim PT
    JAMA; 2016 Jan; 315(2):142-9. PubMed ID: 26757463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.